THE ASSOCIATION BETWEEN MELATONIN ADMINISTRATION AND SLEEP QUALITY IN ACUTE ISCHEMIC STROKE PATIENTS
Keywords:
ischemic stroke, sleep disorders, melatonin, treatment strategyAbstract
Stroke is a leading cause of disability and mortality all over the world. Due to an aging population, the incidence of stroke is rising significantly, which has led to devastating consequences for patients. In addition to traditional risk factors such as age, hypertension, hyperlipidemia, diabetes and atrial fibrillation, sleep disorders, as independent modifiable risk factors for stroke, have been highlighted increasingly.
The aim of the study: To assess the association of Melatonin administration during an acute phase of ischemic stroke patients towards sleep quality
Materials and methods: This study used a randomized control trial design
Subjects participated from the department of Intensive Therapy in Multidisciplinary clinic of Tashkent Medical Academy. Participants are 32 acute ischemic stroke patients. Eligible subjects divided into 2 main groups with simple random sampling method. First group consisted of 16 subjects who received Melatonin, twice daily for 30 days and second group consisted of 16 subjects received placebo, twice daily for 30 days. No major adverse effect was reported during observation.
Results: Sleep quality were measured by The Pittsburgh Sleep Quality Index (PSQI) questionaire at day 1 of admission and at day 30 of the study when subjects returned for routine checkup at Neurology clinic for each subject. PSQI global score ≤ 5 indicates good sleep quality while global score > 5 indicates a poor sleep quality. Subjects were mainly male (56,3%), mean age of 59,6 ± 10,8 years. Measurement at day 1 indicated poor sleep quality on both group with PSQI global score 7,9 ± 2,0. Upon completion group who received Melatonin twice daily marked an improvement in PSQI global score from mean score of 7,8 ± 1,7 at day 1 to mean score of 5,1 ± 2,4 at day 30. No remarkable improvement from Placebo group with similar mean score before and after protocol (8,0 ± 2,4 at day 1 vs 6,9 ± 3,1 at day 30).
Conclusions: There is an association between melatonin administration and sleep quality of acute ischemic stroke patients.
References
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century. Stroke. 2013;44:1–26.
Lindsay MP, Norrving B, Saco RL, Brainin M, Hacke W, Martins S, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. Int. J Stroke. 2019;14(8):806-817.
Rasyid A, Hidayat R, Harris S, Kurniawan M, Mesiano T. Stroke Iskemik. Dalam: Anindhita T, Wiratman W(editor). Buku Ajar Neurologi. 1st ed. Jakarta: Penerbit Kedokteran Indonesia, 2017. 452-568.
Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: The stroke recovery and rehabilitation roundtable taskforce. International Journal of
Stroke. 2017;12(5):444–50.
Hepburn M, Bollu PC, French B, Sashota P. Sleep Medicine: Stroke and Sleep. Missouri Medicine. 2018;115(6).
Culebras A. Sleep, stroke and cardiovascular disease. 1st ed. Cambridge: Cambridge Univ. Press; 2013.
Dib S, Ramos AR, Wallace DM, Rundek T. Sleep and stroke. Periodicum Biologorum. 2012;114(3):369-75.
Islamiyah WR. Panduan Tatalaksana Gangguan Tidur. 2nd ed. Jakarta: Sagung Seto; 2018.
Awan KK, Farooq MT, Farooq P, Tarar MY. The sleep quality using Pittsburgh Sleep Quality Index.PJNS; 2018;13(2)
Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro C, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Medicine Reviews [Internet]. 2016 [cited 17 March 2022];25:52-73. Available from:
https://www.sciencedirect.com/science/article/abs/pii/S1087079215000210?via%3Dihub
Turkowitch D, Ludwig R, Nelson E, Drerup M, Siengsukon CF. Telehealth-delivered cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot study. Multiple Sclerosis International. 2022;2022:1–8. doi:10.1155/2022/7110582
Bush AL, Armento MEA, Weiss BJ, Rhoades HM, Novy DM et al. The Pittsburgh Sleep Quality Index in Older Primary Care Patients with Generalized Anxiety Disorder: Pyschometrics and Outcomes Following Cognitive Behavioral Therapy. Psychiatry Res. 2012 August 30; 199(1): 24–30. doi:10.1016/j.psychres.2012.03.045.
Hasan F, Gordon C, Wu D, Huang H, Yuliana L, Susatia B et al. Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack. Stroke. 2021;52(2):655-663.
Khot S, Morgenstern L. Sleep and Stroke. Stroke [Internet]. 2019 [cited 20 March 2022];50(6):1612-1617. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.023553
Sterr A, Kuhn M, Nissen C, Ettine D, Funk S, Feige B et al. Post-stroke insomnia in community-dwelling patients with chronic motor stroke: Physiological evidence and implications for stroke care. Scientific Reports. 2018;8(1).
Duss S, Brill A, Bargiotas P, Facchin L, Alexiev F, Manconi M et al. Sleep-Wake Disorders in Stroke—Increased Stroke Risk and Deteriorated Recovery? An Evaluation on the Necessity for Prevention and Treatment. Current Neurology and Neuroscience Reports. 2018;18(10)
Karaca B. Factors Affecting Poststroke Sleep Disorders. J Stroke and Cerebrovascular Diseases. Mar 2016;25(3):727–32.
Andrabi S, Parvez S, Tabassum H. Melatonin and Ischemic Stroke: Mechanistic Roles and Action. Advances in Pharmacological Sciences. 2015;2015:1-11.
Hao S, Zhong Z, Qu W, Huang Z, Sun F, Qiu M. Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats. Brain and Behavior [Internet]. 2021 [cited 17 March 2022];11(10). Available from:
https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.2366
Romero A, Ramos E, Patiño P, Oset-Gasque M, López-Muñoz F, Marco-Contelles J et al. Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Frontiers in Aging Neuroscience. 2016;8.
Vinogradov O, Ivanova D, Davidov N, Kuznetsov A. Melatonin in the correction of sleep in post-stroke patients. Zhurnal nevrologii i psikhiatrii im SS Korsakova [Internet]. 2015 [cited 17 March 2022];115(6):86. Available from: https://pubmed.ncbi.nlm.nih.gov/26356402/
Zhang T, Zhang W, Li F. Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trial. Neural Regeneration Research. 2017;12(8):1299.
Ferracioli-Oda E, Qawasmi A, Bloch M. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS ONE. 2013;8(5):e63773.
Kasim S, Zhang B, Harrouk W, Assante K. Melatonin Pharmacy Compounding Advisory Committee Meeting. The U.S. Food & Drug Administration. 2021.
Harpsøe N, Andersen L, Gögenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. European Journal of Clinical Pharmacology [Internet]. 2015 [cited 7 April 2022]; 71(8):901-909. Available from: https://pubmed.ncbi.nlm.nih.gov/26008214/
Badan Pengawasan Obat dan Makanan Republik Indonesia. Rancangan Keputusan Kepala Badan Tentang Penetapan dan Pengawasan Melatonin Sebagai Suplemen Kesehatan Untuk Keperluan Khusus [Internet]. BPOM RI. Jakarta. 2020.
Available at https://jdihn.go.id/files/1953/2020kepkabpom-.pdf
Kamkar M, Mahyar M, Maddah S, Khoddam H, Modanloo M. The effect of melatonin on quality of sleep in patients with sleep disturbance admitted to post coronary care units: a randomized controlled trial. BioMedicine. 2021;11(1):34-40.
Scheer F, Morris C, Garcia J, Smales C, Kelly E, Marks J et al. Repeated Melatonin Supplementation Improves Sleep in Hypertensive Patients Treated with Beta-Blockers: A Randomized Controlled Trial. Sleep. 2012;35(10):1395-1402.
Mehrpooya M, Mazdeh M, Rahmani E, Khazaie M, Ahmadimoghaddam D. Melatonin supplementation may benefit patients with acute ischemic stroke not eligible for reperfusion therapies: Results of a pilot study. Journal of Clinical Neuroscience. 2022;106:66–75.
Vebrian HR, Ganissiregar MF, Adenin I, Sihite H, Ardiansyah E, Dina S, Eyanoer CP. Effect of PSQI score on Administration Melatonin in Perimenopause Women”. International Journal of Current Pharmaceutical Research, vol. 12, no. 4, July 2020, pp. 118-21, doi:10.22159/ijcpr.2020v12i4.39097.
Sadanandan N, Cozene B, Cho J, Park Y, Saft M, Gonzales-Portillo B et al. Melatonin—A Potent Therapeutic for Stroke and Stroke-Related Dementia. Antioxidants [Internet]. 2020 [cited 22 March 2022];9(8):672. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463751/pdf/antioxidants-09-00672.pdf
Ramos E, Farré-Alins V, Egea J, López-Muñoz F, Reiter RJ, Romero A. Melatonin's efficacy in stroke patients; a matter of dose? A systematic review. Toxicology and Applied Pharmacology. 2020;392:114933.
